Opioid Use Disorder, Overdose
Conditions
Keywords
Harm Reduction, Criminal Justice, Pharmacy Practice
Brief summary
The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carceral setting. In this study, participants will be screened for opioid use, trained to administer Narcan nasal spray, receive motivational counseling and referral to treatment post-release from a carceral setting (a Re-Entry program) into the community.
Detailed description
The main objectives of this study are: 1. To increase understanding of racial/ethnic differences in the prevalence of OUD. 2. To test if a pharmacist-led intervention is more effective than a substance use counselor (lay person) in increasing knowledge and confidence among different racial/ethnic groups related to administering Narcan nasal spray in an opioid overdose situation. 3. To test if a pharmacist-delivered an evidence-based intervention, q brief intervention and referral to treatment (BIRT) versus standard medication counseling (SMC) is more effective in increasing access to MOUD.
Interventions
BEHAVIORALPharmacist Narcan Training
A 20-45-minute didactic presentation conducted with a skills training component designed to demonstrate appropriate administration of the Narcan nasal spray.
BEHAVIORALBIRT
BIRT participants will receive a 30-45-minute session delivered by the pharmacist to introduce and encourage treatment options, MOUD information, OUD information, and treatment facility information (i.e., flyers (RDD study/CAST clinic/State Opioid Response III funded agencies) and educational materials), and a referral to treatment/linkage to service providers.
BEHAVIORALSMC
SMS participants will receive a 5-10-minute counseling session delivered by the pharmacist providing MOUD information, OUD information, and treatment facility information (i.e., flyers (RDD study/CAST clinic/State Opioid Response III funded agencies) and educational materials).
BEHAVIORALSubstance Use Counselor Narcan Training
A 20-45-minute didactic presentation conducted with a skills training component designed to demonstrate appropriate administration of the Narcan nasal spray.
Sponsors
University of Arkansas
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Narcan Training: * a Re-Entry program participant 7-14 days from release from carceral setting * provide collateral contact information for ≥2 persons (to ensure consistent contact/follow up) * have a reliable landline or mobile phone to be contacted by pharmacist * plan to remain in the Little Rock area for at least 6 months * able to read and write English * able to provide informed consent * possesses manual dexterity; physical ability to roll a person onto her/his/their back and side * have no allergy to naloxone hydrochloride (active ingredient in Narcan nasal spray)- * identified on the RODS screener as positive for OUD. BIRT/SMC: * a Re-Entry program participant 7-14 days from release from the carceral setting * provide contact information for ≥2 persons (to ensure consistent contact/follow -up) * have a reliable landline or mobile phone to be contacted by pharmacist * plan to remain in the Little Rock area for at least 6 months * able to read and write English; able to provide informed consent * identified with OUD.
Exclusion criteria
Narcan training: * not a RE-entry program participant * identified substance use disorders other than OUD BIRT/SMC: * not a RE-entry program participant * identified substance use disorders other than OUD
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid overdose training | at month 6 | Participants' knowledge about opioid overdose and confidence to recognize and respond to opioid overdose situations as a function of the trainer. Participants will complete a brief validated survey, the adapted Perceived Competence Scale. The questions on the survey are rated on a 7-point scale and participants indicate how true four statements are about their ability to recognize and respond to overdoses: the scale, 1 (not at all true) to 7 (very true). |
| Retention | at month 6 | Participants, regardless of treatment arm, will receive follow-up telephone interviews at 6 months post-release from the carceral setting into the community. Interviews will address the primary question whether MOUD treatment was initiated and maintained. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORMeghan N Breckling, PharmD
UAMS
Outcome results
None listed